The quality of reports of randomized trials in multiple sclerosis: A review

Multiple Sclerosis Journal

Volumn 18, Issue 6, 2012, Pages 776-781

  Signori, Alessio ^a   Baccino, Alice ^a   Sormani, Maria Pia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

clinical trials methodology; CONSORT statement; Randomized clinical trials; subgroup analysis

Indexed keywords

CLINICAL TRIAL; FEASIBILITY STUDY; HUMAN; MEDICAL RESEARCH; METHODOLOGY; MULTIPLE SCLEROSIS; RANDOMIZATION; REVIEW; STATISTICAL ANALYSIS;

EID: 84861811529     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512444327     Document Type: Review

References (21)

1. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology. 1993 ; 43 (4). 655-661
2. Polman CH, Reingold SC, Barkhoff , et al. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Neurology. 2008 ; 70: 1134-1140
3. Sormani MP, Bonzano L, Roccatagliata L, et al. Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach. Ann Neurol. 2009 ; 65: 268-275
4. Sormani MP, Bonzano L, Roccatagliata L, et al. Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach. Neurology. 2010 ; 75: 302-309
5. Friede T, Parsons N, Stallard N, et al. Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis. Stat Med. 2011 ; 30 (13). 1528-1540
6. Chataway J, Nicholas R, Todd S, et al. A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis. Mult Scler. 2011 ; 17: 81-88
7. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996 ; 276: 637-639
8. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001 ; 357: 1191-1194
9. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Int Med. 2010 ; 152: 726-732
10. Assmann SF, Pocock SJ, Enos LE, et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000 ; 355: 1064-1069
11. Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994 ; 13: 1715-1726
12. Altman DG. Comparability of randomised groups. Statistician. 1985 ; 34: 125-136
13. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomised clinical trials. JAMA. 1991 ; 266: 93-98
14. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med. 1987 ; 317: 426-432
15. O'Connor P, Kinkel RP, Kremenchutzky M. Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria. Mult Scler. 2009 ; 15: 728-734
16. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004 ; 170: 477-480
17. Montgomery JH, Byerly M, Carmody T, et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Control Clin Trials. 2004 ; 25: 598-612
18. Fam Pract. Yaphe J Edman R Knishkowy B, ed. 2001: 565-568.
19. Thomas O, Thabane L, Douketis J, et al. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond). 2008 ; 32: 1531-1536
20. Rios LP, Odueyungbo A, Moitri MO, et al. Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab. 2008 ; 93: 3810-3816
21. Khan NA, Lombeida JI, Singh M, et al. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Arthritis Rheum. 2012 ;: